Assessment of racial differences in the incidence of thrombocytopenia induced by trastuzumab emtansine: a systematic review and meta-analysis

BACKGROUND: Trastuzumab emtansine (T-DM1) has been proved to have value and efficacy in the treatment of advanced metastatic cancer, including in the adjuvant setting. However, there is increasing concern about T-DM1-induced thrombocytopenia (TCP), which shows racial differences in incidence. This m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingyi, Yang, Yaning, Chen, Ru, Chen, Shanshan, Wang, Jiayu, Luo, Yang, Ma, Fei, Xu, Binghe, Fan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350666/
https://www.ncbi.nlm.nih.gov/pubmed/34430580
http://dx.doi.org/10.21037/atm-21-2763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350666/
https://www.ncbi.nlm.nih.gov/pubmed/34430580
http://dx.doi.org/10.21037/atm-21-2763

Ejemplares similares